title: [Do genetic factors reduce the effects of clopidogrel?].
authors.forename: R E
authors.initials: RE
authors.lastname: Scharf
mesh_terms: D000241:Adenosine / Q000009:adverse effects / Q000031:analogs & derivatives / Q000493:pharmacokinetics / Q000627:therapeutic use; D000077144:Clopidogrel; D003577:Cytochrome P-450 Enzyme System / Q000235:genetics; D014644:Genetic Variation / Q000235:genetics; D005838:Genotype; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D007527:Isoenzymes / Q000235:genetics; D010597:Pharmacogenetics; D010879:Piperazines / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D010974:Platelet Aggregation / Q000187:drug effects / Q000235:genetics; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D000068799:Prasugrel Hydrochloride; D012307:Risk Factors; D013876:Thiophenes / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D000077486:Ticagrelor; D013988:Ticlopidine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D007527:Isoenzymes; D010879:Piperazines; D010975:Platelet Aggregation Inhibitors; D013876:Thiophenes; D003577:Cytochrome P-450 Enzyme System; D000077144:Clopidogrel; D000068799:Prasugrel Hydrochloride; D000077486:Ticagrelor; D000241:Adenosine; D013988:Ticlopidine